Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
9517.T Stock Summary
In the News
9517.T Financial details
Company Rating
Sell
Market Cap
42.81B
Income
-12.64B
Revenue
258.91B
Book val./share
821.96
Cash/share
213.3
Dividend
22
Dividend %
2.67%
Employees
263
Optionable
No
Shortable
Yes
Earnings
10 May 2024
P/E
-7.48
Forward P/E
9.78
PEG
0.32
P/S
0.17
P/B
0.88
P/C
3.25
P/FCF
-
Quick Ratio
1.23
Current Ratio
1.66
Debt / Equity
1.15
LT Debt / Equity
0.65
-
-
EPS (TTM)
-213.04
EPS next Y
70.83
EPS next Q
-122
EPS this Y
-5.03%
EPS next Y
-133.25%
EPS next 5Y
-136.01%
EPS last 5Y
23.23%
Revenue last 5Y
35.1%
Revenue Q/Q
-2.43%
EPS Q/Q
-35.84%
-
-
-
-
SMA20
-4.2%
SMA50
-13.68%
SMA100
-2.62%
Inst Own
-
Inst Trans
-
ROA
-4%
ROE
-11%
ROC
-0.06%
Gross Margin
2%
Oper. Margin
-2%
Profit Margin
-2%
Payout
-
Shs Outstand
59.38M
Shs Float
30.2M
-
-
-
-
Target Price
-
52W Range
524.0-1890.0
52W High
-63.33%
52W Low
+32.25%
RSI
43
Rel Volume
0.71
Avg Volume
903.69K
Volume
638.3K
Perf Week
-3.62%
Perf Month
-5.33%
Perf Quarter
-9.65%
Perf Half Y
-11.04%
-
-
-
-
Beta
0.853
-
-
Volatility
9.88%, 18.11%
Prev Close
0.58%
Price
693
Change
-2.53%
9517.T Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-03-31
Metric | History | 2019-03-31 | 2020-03-31 | 2021-03-31 | 2022-03-31 | 2023-03-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 1.3K | 1.75K | 2.63K | 3.9K | 5.01K | |
Net income per share | 54.63 | 89.01 | 116.28 | 163.44 | 155.21 | |
Operating cash flow per share | 112.23 | 128.36 | 346.04 | 225.39 | 363.09 | |
Free cash flow per share | -325.2 | -176.69 | 297.65 | -10.07 | 339.99 | |
Cash per share | 137.88 | 185.97 | 434.44 | 188.9 | 173.16 | |
Book value per share | 384.1 | 515.41 | 815.46 | 943.32 | 1.05K | |
Tangible book value per share | 473.7 | 638.49 | 933.92 | 1.05K | 1.17K | |
Share holders equity per share | 384.1 | 515.41 | 815.46 | 943.32 | 1.05K | |
Interest debt per share | 697.74 | 1.02K | 891.18 | 915.87 | 939.24 | |
Market cap | 51.96B | 62.44B | 99.78B | 102.3B | 108.37B | |
Enterprise value | 76.74B | 97.54B | 115.75B | 128.73B | 129.87B | |
P/E ratio | 18.8 | 13.83 | 15.88 | 10.6 | 11.8 | |
Price to sales ratio | 0.79 | 0.7 | 0.7 | 0.44 | 0.37 | |
POCF ratio | 9.15 | 9.59 | 5.33 | 7.68 | 5.04 | |
PFCF ratio | -3.16 | -6.97 | 6.2 | -171.92 | 5.39 | |
P/B Ratio | 2.67 | 2.39 | 2.26 | 1.84 | 1.75 | |
PTB ratio | 2.67 | 2.39 | 2.26 | 1.84 | 1.75 | |
EV to sales | 1.17 | 1.1 | 0.82 | 0.56 | 0.44 | |
Enterprise value over EBITDA | 12.33 | 8.44 | 5.78 | 6.77 | 5.93 | |
EV to operating cash flow | 13.51 | 14.98 | 6.19 | 9.67 | 6.04 | |
EV to free cash flow | -4.66 | -10.88 | 7.19 | -216.35 | 6.45 | |
Earnings yield | 0.05 | 0.07 | 0.06 | 0.09 | 0.08 | |
Free cash flow yield | -0.32 | -0.14 | 0.16 | -0.01 | 0.19 | |
Debt to equity | 1.8 | 1.96 | 1.08 | 0.96 | 0.89 | |
Debt to assets | 0.47 | 0.49 | 0.37 | 0.34 | 0.32 | |
Net debt to EBITDA | 3.98 | 3.04 | 0.8 | 1.39 | 0.98 | |
Current ratio | 1.28 | 1.4 | 1.84 | 1.62 | 1.64 | |
Interest coverage | 19.43 | 24.66 | 31.44 | 24.9 | 32.29 | |
Income quality | 1.32 | 0.74 | 1.38 | 0.96 | 1.4 | |
Dividend Yield | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
Payout ratio | 0.22 | 0.13 | 0.16 | 0.11 | 0.14 | |
Sales general and administrative to revenue | 0.08 | 0.07 | 0.05 | 0.04 | 0.03 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.02 | 0.02 | 0.03 | 0.03 | 0.03 | |
Capex to operating cash flow | -3.9 | -2.38 | -0.14 | -1.04 | -0.06 | |
Capex to revenue | -0.34 | -0.17 | -0.02 | -0.06 | 0 | |
Capex to depreciation | -13.16 | -6.72 | -0.65 | -2.71 | -0.23 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 687.12 | 1.02K | 1.46K | 1.86K | 1.91K | |
ROIC | 0.06 | 0.09 | 0.11 | 0.09 | 0.08 | |
Return on tangible assets | 0.04 | 0.04 | 0.05 | 0.06 | 0.06 | |
Graham Net | -663.89 | -937.11 | -622.61 | -835.36 | -916.56 | |
Working capital | 4.91B | 10.42B | 25.09B | 26.5B | 30.93B | |
Tangible asset value | 23.97B | 32.39B | 50.48B | 62.16B | 69.31B | |
Net current asset value | -27B | -34.23B | -18.34B | -20.89B | -17.76B | |
Invested capital | 1.8 | 1.96 | 1.08 | 0.96 | 0.89 | |
Average receivables | 10.82B | 14.27B | 18.99B | 29.69B | 40.3B | |
Average payables | 4.91B | 5.95B | 7.67B | 12.65B | 17.65B | |
Average inventory | 315.5M | 779.5M | 1.32B | 1.57B | 2B | |
Days sales outstanding | 62.55 | 71.1 | 53.27 | 61.23 | 51.64 | |
Days payables outstanding | 37.49 | 30.98 | 28.45 | 28.4 | 25.82 | |
Days of inventory on hand | 2.3 | 6.05 | 4.48 | 2.97 | 3.12 | |
Receivables turnover | 5.84 | 5.13 | 6.85 | 5.96 | 7.07 | |
Payables turnover | 9.74 | 11.78 | 12.83 | 12.85 | 14.14 | |
Inventory turnover | 158.57 | 60.37 | 81.47 | 122.8 | 117.08 | |
ROE | 0.14 | 0.17 | 0.14 | 0.17 | 0.15 | |
Capex per share | -437.43 | -305.05 | -48.4 | -235.46 | -23.1 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q3
Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 1.42K | 1.26K | 943.63 | 1.1K | 1.07K | |
Net income per share | 23.68 | 54.84 | -64.09 | -124.16 | -79.66 | |
Operating cash flow per share | 50.74 | 49.69 | 33.25 | 33.04 | 33.48 | |
Free cash flow per share | 50.74 | 49.69 | 33.25 | 33.04 | 33.48 | |
Cash per share | 758.84 | 419.87 | -170.64 | 155.74 | 213.3 | |
Book value per share | 1.03K | 1.05K | 1.03K | 933.11 | 821.96 | |
Tangible book value per share | 1.17K | 1.17K | 1.1K | 984.56 | 879.31 | |
Share holders equity per share | 1.03K | 1.05K | 1.03K | 933.11 | 821.96 | |
Interest debt per share | 957.22 | 932.33 | 753.14 | 863.08 | 949.97 | |
Market cap | 128.51B | 108.48B | 66.88B | 45.5B | 46.33B | |
Enterprise value | 131.98B | 129.99B | 93.99B | 74.45B | 77.1B | |
P/E ratio | 22.93 | 8.35 | -4.4 | -1.54 | -2.45 | |
Price to sales ratio | 1.53 | 1.45 | 1.2 | 0.7 | 0.73 | |
POCF ratio | 42.81 | 36.85 | 33.95 | 23.21 | 23.33 | |
PFCF ratio | 42.81 | 36.85 | 33.95 | 23.21 | 23.33 | |
P/B Ratio | 2.1 | 1.75 | 1.1 | 0.82 | 0.95 | |
PTB ratio | 2.1 | 1.75 | 1.1 | 0.82 | 0.95 | |
EV to sales | 1.57 | 1.74 | 1.68 | 1.15 | 1.22 | |
Enterprise value over EBITDA | 43.96 | 175.42 | -17.99 | -16.83 | -18.38 | |
EV to operating cash flow | 43.96 | 44.15 | 47.71 | 37.99 | 38.82 | |
EV to free cash flow | 43.96 | 44.15 | 47.71 | 37.99 | 38.82 | |
Earnings yield | 0.01 | 0.03 | -0.06 | -0.16 | -0.1 | |
Free cash flow yield | 0.02 | 0.03 | 0.03 | 0.04 | 0.04 | |
Debt to equity | 0.92 | 0.89 | 0.73 | 0.92 | 1.15 | |
Debt to assets | 0.31 | 0.32 | 0.32 | 0.34 | 0.39 | |
Net debt to EBITDA | 1.15 | 29.02 | -5.19 | -6.54 | -7.34 | |
Current ratio | 1.67 | 1.64 | 1.85 | 1.66 | 1.71 | |
Interest coverage | 30.04 | 4.82 | -105.84 | -53.67 | -29.27 | |
Income quality | 2.14 | 0.91 | -0.52 | -0.27 | -0.42 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0 | 0.03 | 0 | 0 | 0 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.03 | 0.03 | 0.04 | 0.04 | 0.04 | |
Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 741.9 | 1.14K | 1.22K | 1.61K | 1.21K | |
ROIC | 0.02 | 0 | -0.05 | -0.06 | -0.04 | |
Return on tangible assets | 0.01 | 0.02 | -0.03 | -0.05 | -0.03 | |
Graham Net | -539.15 | -668.69 | -854.02 | -736.35 | -746.03 | |
Working capital | 37.97B | 30.93B | 28B | 26.33B | 28.28B | |
Tangible asset value | 69.28B | 69.31B | 64.95B | 58.4B | 52.16B | |
Net current asset value | -11.9B | -17.76B | -10.3B | -18.03B | -18.45B | |
Invested capital | 0.92 | 0.89 | 0.73 | 0.92 | 1.15 | |
Average receivables | 37.51B | 40.09B | 40.81B | 39.75B | 38.73B | |
Average payables | 27.25B | 24.21B | 15.38B | 13.37B | 14.89B | |
Average inventory | 2.16B | 2.27B | 2.15B | 2.35B | 2.91B | |
Days sales outstanding | 40.92 | 50.58 | 63.89 | 55.14 | 53.42 | |
Days payables outstanding | 33.85 | 24.17 | 17.73 | 20.25 | 20.21 | |
Days of inventory on hand | 2.57 | 2.92 | 3.03 | 3.65 | 4.27 | |
Receivables turnover | 2.2 | 1.78 | 1.41 | 1.63 | 1.68 | |
Payables turnover | 2.66 | 3.72 | 5.08 | 4.44 | 4.45 | |
Inventory turnover | 35.02 | 30.84 | 29.72 | 24.68 | 21.06 | |
ROE | 0.02 | 0.05 | -0.06 | -0.13 | -0.1 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
9517.T Frequently Asked Questions
What is eREX Co.,Ltd. stock symbol ?
eREX Co.,Ltd. is a JP stock and trading under the symbol 9517.T
What is eREX Co.,Ltd. stock quote today ?
eREX Co.,Ltd. stock price is $693 today.
Is eREX Co.,Ltd. stock public?
Yes, eREX Co.,Ltd. is a publicly traded company.